Biodexa Pharmaceuticals (BDRX) Property, Plant & Equipment (Net) (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) Property, Plant & Equipment (Net) (2013 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	66,140.12 Bn	66,139.83 Bn	-	642,333.36
2	Nanobiotix	1,912.79 Bn	1,912.73 Bn	-	5.32 Mn
3	Akari Therapeutics	1,022.34 Bn	1,022.34 Bn	-	-
4	BeOne Medicines	472.60 Bn	467.81 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	122.34 Bn	115.09 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	70.14 Bn	61.39 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.79 Bn	62.79 Bn	-	-
8	Argenx Se	56.19 Bn	51.00 Bn	1.41 Bn	1.96 Bn
9	Alnylam Pharmaceuticals	37.50 Bn	34.49 Bn	959.66 Mn	518.26 Mn
10	Biodexa Pharmaceuticals	17.23 Bn	17.22 Bn	-	121,045.12

Download Data